Caidya

Please join us in giving a warm welcome to Jonathan Kornstein as our new Vice President and Therapeutic Area Leader for Rare Disease and Pediatrics! With nearly three decades of experience in both CROs and pharmaceutical companies, Jonathan brings a treasure trove of expertise in navigating intricate therapeutic landscapes. Jonathan’s leadership will be instrumental as we enhance our commitment to addressing the unique challenges in rare diseases and pediatric care. In his new role, Jonathan will spearhead the growth and strategic development of these crucial areas at Caidya, helping us design, develop, and advance treatments for rare diseases. We're thrilled to have him on board! https://ow.ly/3EA450TRhYf #WelcomeAboard #CaidyaEmployeeSpotlight #Raredisease #Pediatrics

At Caidya, we understand that cell and gene therapies (CGT) bring unique challenges, from complex manufacturing processes to intricate regulatory strategies and patient selection. That's why we're committed to a personalized approach in every clinical trial we manage. Each therapy has its own scientific and medical profile, and we tailor our strategies to meet these specific needs. Advance your CGT development process with Caidya now: https://ow.ly/mHvs50TRhZA #GeneTherapy #CellTherapy #CGT

#ICYMI: Celebrating excellence in clinical research! Congratulations to Kara Alberg, Ciara Cyr, Ambily Dileep, Taylor Tointon, Helen Tran, and Tiffany Walker from Caidya for winning Gold at the PharmaTimes Clinical Researcher of the Year – The Americas 2024. Your success in the Study Start-up phase is a testament to your hard work and passion. #Caidya #GoldStandard #ResearchExcellence #WomenInScience https://ow.ly/wUPy50TRe6M

Caught you scrolling on the weekend! At Caidya, we're always excited to share our latest breakthroughs, even on a Saturday. Did you know a recent study presented at SLEEP 2024 found a link between social media use, sleep duration, and brain activity in teens? It turns out, less sleep and more screen time could be reshaping our teens' brains, particularly in areas responsible for decision-making and pleasure. Fascinating, right? #WeekendReads https://ow.ly/93mN50TRhZg

Meet Stephanie H. Bagully, PhD, our new Vice President and Therapeutic Area Head in Oncology & Hematology. We're thrilled to have her join the Caidya family. With a PhD in oncological research and a background in biochemistry, Stephanie brings not only deep expertise but also an unyielding passion for addressing unmet medical needs. Her dedication aligns perfectly with our mission to innovate and make a real difference in patients' lives. Stephanie will lead our efforts in advancing traditional and cutting-edge therapies, such as Immuno-oncology, Cell and Gene Therapy (#CGT), #Vaccines, and Medical Monitoring Services. Her insights and experience will be instrumental in driving our work forward and breaking new ground in #oncology and #hematology. https://ow.ly/szXL50TRhOy Please join us in welcoming Stephanie to the team. We're excited about the future and the impact we'll make together! 🎊 #PatientsNeedOptions #PatientsNeedResearch #WelcomeAboard #CaidyaEmployeeSpotlight

A big round of applause for Kara Alberg, Ciara Cyr, Ambily Dileep, Taylor Tointon, Helen Tran, and Tiffany Walker from Caidya's The Trial Titans: Women’s Edition for winning Gold at the PharmaTimes Clinical Researcher of the Year – The Americas 2024! Your hard work and perseverance in the Study Start-up phase have paid off. We're so proud of your achievements. Keep inspiring and breaking barriers! #WomenInScience #CaidyaGold #Trailblazers https://ow.ly/pLgR50TRe44

There's still time to catch Jonathan Kornstein, Vice President of Rare Disease and Pediatrics at Caidya, leading today's panel on "What are the impacts of rare designation?" Join us at 11:10 AM to explore how this crucial status advances research and drug approvals, shaping the future of rare disease treatments. Don’t miss out on this insightful session! Join us now: https://ow.ly/87G350TRiaF #RareDisease #HealthcareInnovation #OrphanDrugCongress

Join Caidya this November 7th in Houston for the 13th Annual Texas Life Science Forum. Meet our experts, including Dr. Nayf Edrees and our Business Development team, to explore how we can support your clinical development projects. #TXLSF2024 #Innovation #Caidya Click here to meet with us: https://ow.ly/NoAL50TRhgV

Huge congratulations to Caidya's Start Up Team, The Trial Titans: Women’s Edition, for winning the Gold award at the PharmaTimes Clinical Researcher of the Year – The Americas 2024! Kara Alberg, Ciara Cyr, Ambily Dileep, MS, ACRP-CP Dileep, Taylor Tointon, Helen Tran, and Tiffany Walker, your dedication and innovation in the Study Start-up phase have truly set you apart. Members of Caidya's executive team were also in attendance last night to cheer them on, and it was a fantastic celebration. Gaurav Sharma David Rifkind Stephanie H. Bagully, PhD Keep leading the way in clinical research! #CaidyaChampions #GoldWinners #InnovationLeaders https://ow.ly/3J7w50TR8vQ

Why invest in rare disease research? Join Jonathan Kornstein at the WODC to explore how the Orphan Drug Designation provides crucial financial incentives and marketing exclusivity, making rare disease drug development viable. Don't miss out on learning about this game-changing approach! https://ow.ly/IRI750TQXvH #WODC2024 #RareDiseases #PharmaLeaders" Schedule your meeting with Caidya now: https://ow.ly/WwvS50TQXvI